Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Durand

Showing results (161-170 of 189) with videos related to

Pageof 19
Sort By:
Clinical Cardiology|December 17, 2017
Impact of coronary artery disease in patients undergoing transcatheter aortic valve replacement: Insights from the FRANCE-2 registryEtienne Puymirat, Romain Didier, Hélène Eltchaninoff, et al.
Circulation. Cardiovascular Quality and Outcomes|June 30, 2011
Upstream use of small-molecule glycoprotein iib/iiia inhibitors in patients with non-ST-segment elevation acute coronary syndromes: a systematic overview of randomized clinical trialsPierluigi Tricoci, L Kristin Newby, Vic Hasselblad, et al.
Medicine|September 15, 2022
Early survival after acute myocardial infarction with ST-segment elevation: What could be improved? Insights from France PCI French registryBenjamin Duband, Pascal Motreff, Pierre Marcollet, et al.
Nature Communications|July 25, 2023
Ezh2 emerges as an epigenetic checkpoint regulator during monocyte differentiation limiting cardiac dysfunction post-MIJulie Rondeaux, Déborah Groussard, Sylvanie Renet, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 8, 2023
Infective Endocarditis After Transcatheter Versus Surgical Aortic Valve ReplacementVassili Panagides, Guillermo Cuervo, Jaume Llopis, et al.
JACC. Cardiovascular Interventions|August 20, 2016
Warfarin and Antiplatelet Therapy Versus Warfarin Alone for Treating Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve ReplacementOmar Abdul-Jawad Altisent, Eric Durand, Antonio J Muñoz-García, et al.
JACC. Cardiovascular Interventions|November 26, 2016
Reply: Antithrombotic Regimen in Post-TAVR Atrial Fibrillation: Not an Easy DecisionOmar Abdul-Jawad Altisent, Eric Durand, Antonio J Muñoz-García, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 4, 2022
Incidence, Clinical Characteristics, and Impact of Absent Echocardiographic Signs in Patients With Infective Endocarditis After Transcatheter Aortic Valve ImplantationNorman Mangner, Vassili Panagides, David Del Val, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 9, 2022
Very early infective endocarditis after transcatheter aortic valve replacementVassili Panagides, Mohamed Abdel-Wahab, Norman Mangner, et al.
Circulation. Cardiovascular Interventions|December 21, 2018
Impact of Preexisting Left Bundle Branch Block in Transcatheter Aortic Valve Replacement RecipientsQuentin Fischer, Dominique Himbert, John G Webb, et al.
Pageof 19

Showing results (161-170 of 189) with videos related to

Sort By:
Pageof 19
Clinical Cardiology|December 17, 2017
Impact of coronary artery disease in patients undergoing transcatheter aortic valve replacement: Insights from the FRANCE-2 registryEtienne Puymirat, Romain Didier, Hélène Eltchaninoff, et al.
Circulation. Cardiovascular Quality and Outcomes|June 30, 2011
Upstream use of small-molecule glycoprotein iib/iiia inhibitors in patients with non-ST-segment elevation acute coronary syndromes: a systematic overview of randomized clinical trialsPierluigi Tricoci, L Kristin Newby, Vic Hasselblad, et al.
Medicine|September 15, 2022
Early survival after acute myocardial infarction with ST-segment elevation: What could be improved? Insights from France PCI French registryBenjamin Duband, Pascal Motreff, Pierre Marcollet, et al.
Nature Communications|July 25, 2023
Ezh2 emerges as an epigenetic checkpoint regulator during monocyte differentiation limiting cardiac dysfunction post-MIJulie Rondeaux, Déborah Groussard, Sylvanie Renet, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 8, 2023
Infective Endocarditis After Transcatheter Versus Surgical Aortic Valve ReplacementVassili Panagides, Guillermo Cuervo, Jaume Llopis, et al.
JACC. Cardiovascular Interventions|August 20, 2016
Warfarin and Antiplatelet Therapy Versus Warfarin Alone for Treating Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve ReplacementOmar Abdul-Jawad Altisent, Eric Durand, Antonio J Muñoz-García, et al.
JACC. Cardiovascular Interventions|November 26, 2016
Reply: Antithrombotic Regimen in Post-TAVR Atrial Fibrillation: Not an Easy DecisionOmar Abdul-Jawad Altisent, Eric Durand, Antonio J Muñoz-García, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 4, 2022
Incidence, Clinical Characteristics, and Impact of Absent Echocardiographic Signs in Patients With Infective Endocarditis After Transcatheter Aortic Valve ImplantationNorman Mangner, Vassili Panagides, David Del Val, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 9, 2022
Very early infective endocarditis after transcatheter aortic valve replacementVassili Panagides, Mohamed Abdel-Wahab, Norman Mangner, et al.
Circulation. Cardiovascular Interventions|December 21, 2018
Impact of Preexisting Left Bundle Branch Block in Transcatheter Aortic Valve Replacement RecipientsQuentin Fischer, Dominique Himbert, John G Webb, et al.
Pageof 19